Why Janux Therapeutics, Inc. (JANX) stock fell 27.6% on Monday, November 9, 2026

Janux Therapeutics, Inc. (JANX) closed at $12.76, down 27.62% on Monday, November 9, 2026, on volume of 4,841,985 shares (5.7× its 3-month average); market value about $800.0M.

What happened: primary sources

Events Nexqual found for JANX on Monday, November 9, 2026 or the trading day before (November 6, 2026):

• Nov 6, 2026: Truist Securities: Target raised, Buy, price target $26 → $27
• Nov 6, 2026: Wedbush: Target raised, Outperform, price target $36 → $40
• Nov 6, 2026: Barclays: Target raised, Underweight, price target $14 → $15

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on JANX

JANX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 9, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:24 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:24 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt